Inventor
DAELKEN BENJAMIN
DE19 patents
⚠️ This page may combine multiple inventors who share the name “DAELKEN BENJAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOTEST AG
6 patentsUS10117932B2Nov 6, 2018
Uses of immunoconjugates targeting CD138
BIOTEST AG7 citations80
US12186391B2Jan 7, 2025
Treatment of severe community acquired pneumonia
BIOTEST AG0 citations57
US11517621B2Dec 6, 2022
Treatment of severe community acquired pneumonia
BIOTEST AG0 citations57
US10918715B2Feb 16, 2021
Treatment of severe community acquired pneumonia
BIOTEST AG0 citations57
US9540436B2Jan 10, 2017
Use of antibodies for detection of IL-10
BIOTEST AG0 citations49
US9605066B2Mar 28, 2017
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
BIOTEST AG0 citations48
OSTERROTH FRANK
5 patentsUS8956607B2Feb 17, 2015
Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)
OSTERROTH FRANK7 citations81
US9289509B2Mar 22, 2016
Uses of immunoconjugates targeting CD138
OSTERROTH FRANK10 citations79
US9334325B2May 10, 2016
Method for treating psoriasis
OSTERROTH FRANK2 citations59
US8852871B2Oct 7, 2014
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
OSTERROTH FRANK3 citations58
US9995733B2Jun 12, 2018
Agents for treating disease
OSTERROTH FRANK1 citations47